Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1622 SEK | +0.75% | +8.71% | -33.93% |
Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Dec. 20 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 171M 16M |
---|---|---|---|---|---|
Net income 2024 * | -142M -13.26M | Net income 2025 * | -157M -14.66M | EV / Sales 2024 * | - |
Net cash position 2024 * | 124M 11.58M | Net cash position 2025 * | 173M 16.15M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.25
x | P/E ratio 2025 * |
-1.08
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
1 day | +0.75% | ||
1 week | +8.71% | ||
Current month | -0.37% | ||
1 month | -0.49% | ||
3 months | -34.20% | ||
6 months | -32.42% | ||
Current year | -33.93% |
Managers | Title | Age | Since |
---|---|---|---|
Ellen Donnelly
CEO | Chief Executive Officer | 50 | 21-02-02 |
Eskil Elmér
FOU | Founder | 54 | 00-01-31 |
Director of Finance/CFO | 57 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 16-04-27 | |
David Bejker
BRD | Director/Board Member | 49 | 17-04-26 |
Eskil Elmér
FOU | Founder | 54 | 00-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.1622 | +0.75% | 1,049,753 |
24-03-27 | 0.161 | +4.14% | 882,691 |
24-03-26 | 0.1546 | +3.62% | 688,524 |
24-03-25 | 0.1492 | +0.13% | 879,348 |
24-03-22 | 0.149 | -0.13% | 1,052,806 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:46 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.93% | 16.04M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |